跳至主要内容
临床试验/EUCTR2010-022046-25-NL
EUCTR2010-022046-25-NL进行中(未招募)1 期

Cholic acid treatment in Peroxisomal Biogenesis Disorders (Zellweger spectrum): biochemical and clinical effects. - Cholic acid in Zellweger

Department of Pediatric Gastroenterology, Academic Medical Centre0 个研究点开始时间: 2010年10月27日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Zellweger spectrum disorder
  • At least one of the following hallmarks: steatorrhea, elevated transaminases, growth retardation, neurological symptoms
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Short life expectancy based on severe multiple organ dysfunction in the first 6 months of life

研究者

发起方
Department of Pediatric Gastroenterology, Academic Medical Centre

相似试验

Cholic acid treatment in Peroxisomal Biogenesis... | 临床试验